CTMC, a joint venture between MD Anderson Cancer Center and Resilience, has entered a partnership with Syenex to advance the ...

CES, LAS VEGAS, January 7, 2025 – QNX, a division of BlackBerry Limited (NYSE: BB; TSX:BB), Vector and TTTech Auto today ...

Package Reputation is an essential capability for organizations seeking to secure their software supply chain. By analyzing ...

Analyst examines TeamViewer's decision to end partnership with Manchester United, highlighting operating profits and concerns ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

LG-631 is under clinical development by Lentigen Technology and currently in Phase II for Glioblastoma Multiforme (GBM).

New Delhi, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The global gene therapy market was valued at US$ 9.42 billion in 2024 and is projected to hit the market valuation of US$ 42.26 billion by 2033 at a CAGR ...

Turning Point Brands has seen a significant turnaround, driven by the entrance into the nicotine pouch category. Read why TPB ...

BlackBerry stock is surging today thanks to a series of announcements from the company's QNX division, which is focused on ...

Multivector nuclear diplomacy (in the best molds of the principles of Kazakhstan’s multi-vector foreign policy) fulfills ...